Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)

NCT00945139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Doxil
DRUG: Avastin

Sponsor

New Mexico Cancer Research Alliance

Collaborators

[object Object]
[object Object]